Expression of human eukaryotic initiation factor 3f oscillates with cell cycle in A549 cells and is essential for cell viability.
BACKGROUND
Transcriptional and postranslational regulation of the cell cycle has been widely studied. However, there is scarce knowledge concerning translational control of this process. Several mammalian eukaryotic initiation factors (eIFs) seem to be implicated in controlling cell proliferation. In this work, we investigated if the human eIF3f expression and function is cell cycle related.


RESULTS
The human eIF3f expression has been found to be upregulated in growth-stimulated A549 cells and downregulated in G0. Western blot analysis and eIF3f promotor-luciferase fusions revealed that eIF3f expression peaks twice in the cell cycle: in the S and the M phases. Deregulation of eIF3f expression negatively affects cell viability and induces apoptosis.


CONCLUSIONS
The expression pattern of human eIF3f during the cell cycle confirms that this gene is cell division related. The fact that eIF3f expression peaks in two cell cycle phases raises the possibility that this gene may exert a differential function in the S and M phases. Our results strongly suggest that eIF3f is essential for cell proliferation.
Higareda-Mendoza
Ana E
AE
Departmento de Biología Molecular, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México. mapardo@umich.mx.
Pardo-Galván
Marco A
MA
Cancer Res. 2003 Nov 1;63(21):7410-22
14612540
J Biol Chem. 1997 Jan 10;272(2):1101-9
8995409
Mol Biol Cell. 2003 Sep;14(9):3942-51
12972576
Oncogene. 2006 Aug 10;25(35):4923-36
16532022
Oncogene. 2004 May 6;23(21):3790-801
15094776
FEBS Lett. 2004 Aug 27;573(1-3):139-46
15327989
Nature. 1987 Apr 2-8;326(6112):501-5
3453121
BMC Biol. 2005 May 17;3:14
15904532
Cell Div. 2007 Sep 24;2:28
17892542
Anticancer Res. 2000 May-Jun;20(3A):1343-51
10928042
Am J Respir Cell Mol Biol. 2003 Nov;29(5):562-70
12748058
Nat Methods. 2005 Oct;2(10):779-84
16179925
Mol Cell Biol. 1993 Dec;13(12):7358-63
8246956
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3220-5
16492757
Genome Res. 2002 Oct;12(10):1455-65
12368238
PLoS One. 2009 Sep 18;4(9):e7064
19763267
Oncogene. 2005 Feb 10;24(7):1203-11
15558017
J Biol Chem. 2004 Mar 5;279(10):8946-56
14688252
Exp Cell Res. 2009 Jul 1;315(11):1889-94
19327350
Plant Cell. 2004 Dec;16(12):3341-56
15548739
Biochemistry. 1982 Aug 31;21(18):4202-6
6181805
Protein Sci. 1998 May;7(5):1250-4
9605331
J Biol Chem. 1995 Apr 21;270(16):9281-8
7721848
Mol Biol Evol. 2009 Jun;26(6):1405-20
19289598
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W113-20
15215362
Crit Rev Oncol Hematol. 2006 Sep;59(3):169-80
16829125
J Biol Chem. 2001 Jan 19;276(3):2122-31
11042177
J Biol Chem. 1978 May 10;253(9):3078-87
641056
Mol Cell Biol. 1998 Aug;18(8):4935-46
9671501
EMBO J. 2008 Apr 23;27(8):1266-76
18354498
EMBO J. 2004 Nov 24;23(23):4615-26
15510213
Cell Prolif. 1997 Feb;30(2):53-60
9332495
J Clin Invest. 2007 Sep;117(9):2638-48
17786246
J Mol Biol. 1970 Jun 28;50(3):655-70
5529301
Mol Cell. 2000 Apr;5(4):607-16
10882097